Journal Article

DKFZ-2026-01855

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Early and late CTCAE and patient-reported outcomes following prostate radiotherapy in the REQUITE cohort.

Heumann, P. (First author)DKFZ* ; Romero, J. C. R. (First author)DKFZ* ; Aguado Barrera, M. E. ; Aguado Flor, E. ; Avuzzi, B. ; Azria, D. ; Briers, E. ; Carballo-Castro, A. ; Chang-Claude, J.DKFZ* ; Choudhury, A. ; Dunning, A. ; Elliott, R. M. ; Fachal, L. ; Farcy-Jacquet, M.-P. ; Gómez-Caamaño, A. ; Gutiérrez-Enríquez, S. ; Herskind, C. ; Kaaks, R.DKFZ* ; Kerns, S. L. ; Lambrecht, M. ; Maldonado, X. ; Michalet, M. ; Chiorda, B. N. ; Peleteiro-Higueiro, P. ; Rattay, T. ; Rosenstein, B. S. ; De Ruysscher, D. ; Sperk, E. ; Stobart, H. ; Symonds, R. P. ; Talbot, C. J. ; Tubío-Abuín, M. A. ; Vega, A. ; Veldeman, L. ; Veldwijk, M. R. ; Ward, T. ; Webb, A. ; West, C. M. L. ; consortia, R. (Collaboration Author) ; Seibold, P. (Last author)DKFZ* ; Rancati, T.

2026
Elsevier Amsterdam

Abstract: Prospectively collected long-term adverse event data with pre-radiotherapy assessment and regular follow-up reflecting 'real world settings' are still limited. Here, we present the available data on early and long-term outcomes up to eight years after radiotherapy in men with prostate cancer who participated in the international REQUITE cohort study, stratified by treatment modalities and patient characteristics.Longitudinal data on pre-radiotherapy, acute and late symptoms up to eight years after radiotherapy were available from 1760 non-metastatic prostate cancer patients recruited in seven European countries and the USA. External beam radiotherapy (EBRT) and/or brachytherapy were given with curative intent between 2014 and 2016 according to local regimens. Gastrointestinal (GI) and genitourinary (GU) symptoms including sexual dysfunction were prospectively assessed by healthcare professionals according to CTCAE v4.0. Patient-reported outcomes were collected.The highest incidence of clinician-reported grade ≥ 2 long-term GI and GU symptoms were for proctitis (12.1%) and haematuria (12.9%) among the EBRT-only treated patients, and proctitis (6.4%) and urinary incontinence (32.4%) among the post-prostatectomy/EBRT patients. Incidence of grade 3 adverse events was below 1.5%, with the only exception of late urinary incontinence in post-prostatectomy patients (10.2%).The frequency and distribution of GI and GU symptoms in a real-world multicentre cohort of patients following prostate radiotherapy were comparable to those reported in large interventional trials. Our finding highlights the value of standardised data farming approaches like the REQUITE project. Most patients consented to provide their data for future cancer research which is available on request.

Keyword(s): Radiotherapy ; adverse events ; patient-reported outcomes ; prospective cohort study

Note: #EA:C020#LA:C130#

---

Contributing Institute(s):

1. Epidemiologie von Krebs (C020)
2. Personalisierte Früherkennung des Prostatakarzinoms (C130)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026

---

Database coverage:
; ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---